Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis
暂无分享，去创建一个
S. Riondino | V. Formica | M. Roselli | H. Arkenau | F. Skoulidis | C. Cremolini | L. Salvatore | V. Conca | M. Schirripa | M. Calegari | C. Morelli | J. Lucchetti | F. Lo Prinzi | Giovanni Dima | E. Dell'Aquila | Marco Messina | G. Trovato